John A. Orwin

Insider Reports History

Entity
Individual
Location
C/O Relypsa, Inc., 700 Saginaw Dr., Redwood City, CA
Signature
/s/ Eric Loumeau, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John A. Orwin:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Travere Therapeutics, Inc. Director Common Stock 28.9K $195K $6.74 May 8, 2024 Direct
ANAPTYSBIO, INC Director Common Stock 3.34K $128K $38.41 Sep 15, 2024 Direct
ANAPTYSBIO, INC Director Restricted Stock Unit 2.6K $99.9K $38.41 Sep 15, 2024 Direct
Atreca, Inc. PRESIDENT & CEO, Director Class A Common Stock 77.5K $29K $0.37 Apr 11, 2024 Direct
ANAPTYSBIO, INC Director Restricted Stock Unit 0 $0 $23.16 Jun 15, 2024 Direct
CARGO Therapeutics, Inc. Director Stock Option (Right to Buy) 23.7K Jun 4, 2024 Direct
Travere Therapeutics, Inc. Director Stock option (right to buy) 19.5K May 8, 2024 Direct
ANAPTYSBIO, INC Director Stock Option (right to buy) 16.5K Jan 3, 2024 Direct
Atreca, Inc. PRESIDENT & CEO, Director Series A Junior Preferred Stock 1 Apr 11, 2024 Direct
Seagen Inc. Director Common Stock 0 $229.00 Dec 14, 2023 Direct
Seagen Inc. Director Restricted Stock Units 0 $229.00 Dec 14, 2023 Direct
Seagen Inc. Director Stock Options (Right to Buy) 0 Dec 14, 2023 Direct

Insider Reports Filed by John A. Orwin

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ANAB ANAPTYSBIO, INC Sep 15, 2024 2 $0 4 Sep 17, 2024 Director
ANAB ANAPTYSBIO, INC Jun 15, 2024 2 $0 4 Jun 18, 2024 Director
CRGX CARGO Therapeutics, Inc. Jun 4, 2024 1 $0 4 Jun 6, 2024 Director
TVTX Travere Therapeutics, Inc. May 8, 2024 2 $0 4 May 10, 2024 Director
BCEL Atreca, Inc. Apr 11, 2024 1 $0.01 4 Apr 17, 2024 PRESIDENT & CEO, Director
ANAB ANAPTYSBIO, INC Jan 3, 2024 2 $0 4 Jan 5, 2024 Director
SGEN Seagen Inc. Dec 14, 2023 11 -$6.64M 4 Dec 15, 2023 Director
CRGX CARGO Therapeutics, Inc. Nov 9, 2023 1 $0 4 Nov 13, 2023 Director
CRGX CARGO Therapeutics, Inc. Nov 9, 2023 0 $0 3 Nov 9, 2023 Director
ANAB ANAPTYSBIO, INC Sep 15, 2023 4 $0 4 Sep 18, 2023 Director
ANAB ANAPTYSBIO, INC Sep 15, 2023 0 $0 3 Sep 18, 2023 Director
BCEL Atreca, Inc. Sep 1, 2023 1 -$8.6K 4 Apr 3, 2024 PRESIDENT & CEO, Director
SGEN Seagen Inc. May 31, 2023 1 $0 4 Jun 2, 2023 Director
TVTX Travere Therapeutics, Inc. May 17, 2023 2 $0 4 May 19, 2023 Director
BCEL Atreca, Inc. Feb 9, 2023 1 $0 4 Feb 13, 2023 President & CEO, Director
BCEL Atreca, Inc. Sep 2, 2022 1 -$37.1K 4 Sep 20, 2022 President & CEO, Director
BCEL Atreca, Inc. Jun 13, 2022 8 $0 4 Jun 15, 2022 President & CEO, Director
SGEN Seagen Inc. May 13, 2022 2 $0 4 May 17, 2022 Director
TVTX Travere Therapeutics, Inc. May 11, 2022 2 $0 4 May 12, 2022 Director
BCEL Atreca, Inc. Dec 23, 2021 1 $0 4 Dec 28, 2021 President & CEO, Director
BCEL Atreca, Inc. Sep 9, 2021 1 $0 4 Sep 13, 2021 President & CEO, Director
TVTX Travere Therapeutics, Inc. May 14, 2021 2 $0 4 May 18, 2021 Director
SGEN Seagen Inc. May 14, 2021 2 $0 4 May 18, 2021 Director